MyelinZ

MyelinZ operates at the intersection of neurotechnology, digital therapeutics, medical devices, and immersive gaming. Its stated differentiation is the combination of wearable sensing, brain-computer interfaces, AI-driven interpretation, and game-based interventions within a “virtual gym” model for the brain and body. That gives the company a broader scope than condition-specific digital therapeutics, although it also creates a demanding validation and regulatory burden. R-MMS targets Multiple Sclerosis monitoring and care, while BodyMirror and BrainMirror-related technologies address cognition, mood, speech, strength, and rehabilitation. MyelinSpace extends the proposition into neuroprotective support for space missions. The two-founder team and Manchester base further suggest an early-stage company building a differentiated platform rather than a mature category incumbent.

MyelinZ was founded on Jan 8, 2021 by Dr Zied Tayeb and Samaher Garbaya, initially establishing a platform thesis around AI, neuroscience, gaming, and human performance. The recorded $1.2 million pre-seed round announced on Jan 26, 2023, backed by imec.istart and Boryung Pharmaceutical, provided early financing for product and validation work. Product development has since expanded across three structured offerings: BodyMirror, R-MMS, and MyelinSpace. The 2024 focus on R-MMS and remote Multiple Sclerosis monitoring indicates movement from a general wellness proposition toward a clinically oriented use case, while MyelinSpace preserves a longer-horizon space-health application. A separate Jun 13, 2025 funding signal describes an $8 million Seed round, although this conflicts with the structured funding total of $1.2 million and should be treated cautiously. Hiring was reported in November 2025 and no layoffs were reported, suggesting continued team formation. Overall, the trajectory shows product diversification and increasing external visibility, but public evidence remains insufficient to confirm commercial scale, regulatory clearance, or sustained employee growth.